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Endogenous Retinoids in the Pathogenesis of
Alopecia Areata
F. Jason Duncan1,7, Kathleen A. Silva2,7, Charles J. Johnson1,7, Benjamin L. King2, Jin P. Szatkiewicz2,
Sonya P. Kamdar2, David E. Ong3, Joseph L. Napoli4, Jinshan Wang4, Lloyd E. King Jr3, David A. Whiting5,
Kevin J. McElwee6, John P. Sundberg2,3 and Helen B. Everts1
Alopecia areata (AA) is an autoimmune disease that attacks anagen hair follicles. Gene array in graft-induced C3H/
HeJ mice revealed that genes involved in retinoic acid (RA) synthesis were increased, whereas RA degradation genes
were decreased in AA compared with sham controls. This was confirmed by immunohistochemistry in biopsies
from patients with AA and both mouse and rat AA models. RA levels were also increased in C3H/HeJ mice with AA.
C3H/HeJ mice were fed a purified diet containing one of the four levels of dietary vitamin A or an unpurified diet
2 weeks before grafting and disease progression followed. High vitamin A accelerated AA, whereas mice that were
not fed vitamin A had more severe disease by the end of the study. More hair follicles were in anagen in mice fed
high vitamin A. Both the number and localization of granzyme B–positive cells were altered by vitamin A. IFNg was
also the lowest and IL13 highest in mice fed high vitamin A. Other cytokines were reduced and chemokines
increased as the disease progressed, but no additional effects of vitamin A were seen. Combined, these results
suggest that vitamin A regulates both the hair cycle and immune response to alter the progression of AA.
Journal of Investigative Dermatology (2013) 133, 334–343; doi:10.1038/jid.2012.344; published online 27 September 2012
INTRODUCTION
Alopecia areata (AA) is an autoimmune, nonscarring, hair loss
disease affecting up to 1.7% of humans (Safavi et al., 1995).
Current treatments are often ineffective in inducing prolonged
remission (Tosti and Duque-Estrada, 2009; Harries et al.,
2010). AA is characterized by a loss of hair follicle immune
privilege, increased IFN gamma (IFNg) and other T helper 1
(Th1) cytokines, and an increase in CD8þ T cells (McElwee
et al., 1996; Gilhar et al., 2005; King et al., 2008). NK or NKT
cells and T regulatory (Tregs) cells may also be involved
(McElwee et al., 2005; Ito et al., 2008; Petukhova et al., 2010).
Studies suggest that AA is a complex polygenetic disease
(Sundberg et al., 2004; Petukhova et al., 2010). Little is known
about the environmental factors, such as diet, that impact the
course of AA.
Several interactions between retinoids and immunity exist
(Duriancik et al., 2010). Vitamin A deficiency impairs the
development of cell-mediated immunity (Smith et al., 1987)
and promotes Th1 responses while delaying Th2 development
(Cantorna et al., 1994). Recently, additional T-cell subtypes
were appreciated as important in autoimmunity, including
Th17 and T Tregs cells, which are both regulated by vitamin A
to maintain gut immune tolerance (Stockinger et al., 2007;
Sojka et al., 2008). Retinoic acid (RA) synthesis occurs in
dendritic cells (DCs) in the gut (Iwata et al., 2004), which
increases FOXP3-positive Tregs (Coombes et al., 2007) and
inhibits Th17 cell development (Mucida et al., 2007) via RA
receptor alpha (RARA) in vitro (Schambach et al., 2007).
Inducing in vivo endogenous RA synthesis through activation
of toll-like receptor 2 (Manicassamy et al., 2009) or PPARG
agonist (Housley et al., 2009) inhibited Th17 cells and
increased FOXP3. Exogenous RA inhibited Th17 cells but
had no effect on FOXP3 (Xiao et al., 2008), suggesting that RA
needs to be induced in a precise location endogenously to
maintain gut immune tolerance. Similar to the gut, skin has
a major barrier function. DCs in the dermis have similar
characteristics to those in the gut, including langerin
expression (Bursch et al., 2007). Mouse ear dermal DCs had
aldehyde dehydrogenase activity and induced FOXP3-positive
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Tregs in an RAR-dependent manner, although it was not
confirmed that these cells also expressed langerin or retinal
dehydrogenase 2 (ALDH1A2, (Guilliams et al., 2010). Collec-
tively, the results from these studies suggest that RA synthesis
within the gut and skin DCs regulates immune tolerance.
Excess RA leads to alopecia (Ruzicka et al., 1992; Ries and
Hess, 1999; Shih et al., 2009), which may result from many
factors including dysregulated immune function. Vitamin A
deficiency leads to follicular hyperkeratosis and rupture in
humans and rodents (Wolbach and Howe, 1925; Girard et al.,
2006). In rodents, vitamin A deficiency also leads to a thin hair
coat that is frequently seen but rarely reported (Anzano et al.,
1979, unpublished observation; Everts and Berdanier, 2002).
The results from these studies suggest that precise RA levels
are needed for optimal hair follicle function.
RA synthesis occurs locally in or near the cells where it will
ultimately be used. Precise spatial and temporal levels of RA
in the skin are achieved by regulating several key steps in
cellular vitamin A metabolism: storage as retinyl esters, RA
synthesis, and RA degradation (Everts, 2012). In brief, vitamin
A circulates as retinol bound to retinol-binding protein (RBP4).
Retinol is transported into the cell via stimulation by RA 6
(STRA6) and binds cellular retinol binding protein 1 (RBP1,
aka CRBP). This bound retinol can either be esterified by
lecithin:retinol acyltransferase (LRAT) for storage or reversibly
oxidized to retinal via retinol dehydrogenases, such as
dehydrogenase reductase SDR family member 9 (DHRS9) or
RDH10. Retinal is further oxidized to RA by retinal
dehydrogenases 1–3 (ALDH1A1–3). RA is then sent to the
nucleus with the assistance of cellular RA binding protein 2
(CRABP2) to bind its RA receptors alpha, beta, and gamma
(RARA, B, C) and activate the transcription of 500þ genes
(Balmer and Blomhoff, 2002). When RBP1/CRBP is saturated
or absent, retinol can be esterified by acyl CoA: diacylglycerol
acyltransferase 1 (DGAT1) or cleared by conversion to retinal
by alcohol dehydrogenases 1–4. Retinal is then oxidized to RA
via ALDH1A1 and further metabolized by cytochrome P450
26 family members (CYP26A1, B1, C1) with the assistance of
cellular RA binding protein 1 (CRABP1).
To better understand AA, transcriptome analysis of C3H/HeJ
mice with AA was performed. As retinoid metabolism was not
part of the network analysis software, the expression of
retinoid metabolism genes was examined with the hypothesis
that RA metabolism was not altered in AA. Transcripts coding
for proteins metabolizing retinoids were altered, which was
confirmed in biopsies from AA patients and rodent AA models.
High dietary vitamin A accelerated disease progression and
numbers of hair follicles in anagen. Lack of vitamin A resulted
in a more severe disease. A few immune factors were also
altered by diet, suggesting that retinoids alter AA by regulating
both the hair cycle and immune response.
RESULTS
The capacity for RA synthesis was increased in AA
Analysis of graft-induced AA transcripts revealed that the
expression of most genes involved in RA synthesis
was significantly increased (Figure 1a, Supplementary Tables
S3–S6 online), whereas the expression of Rbp4 and RA
degradation genes was significantly decreased (Figure 1b) in
AA compared with sham controls at 10, 15, and sometimes 20
weeks after grafting. Only Rbp1 (Crbp1), Crabp2, and Aldh1a3
transcripts were significantly increased and Stra6 significantly
decreased in mice with spontaneous AA compared with wild-
type C3H/HeJ mice (Figure 1c).
Because differences in the hair cycle between the AA mice
and controls were found (Supplementary Figure S2 online) and
RA synthesis components changed during the hair cycle
(Everts et al., 2007), these gene array results were confirmed
using immunohistochemistry (IHC) on human, DEBR rat, and
C3H/HeJ mouse skin, with or without AA, using antibodies
against specific RA synthesis and degradation proteins to
better control for hair cycle changes. RBP1/CRBP had the
greatest increase in immunoreactivity in biopsies of patients
with AA and both rodent models (Figure 2a–d and
Supplementary Figure S3a and b online). RBP1/CRBP was
also high in CBA/CaHN-Btkxnl/J, SWR/J, and A/J mice with AA,
but not in C3H/HeOuJ mice with AA (Supplementary
Figure S4 online). DHRS9 and CRABP2 were also increased
in mice but only slightly increased in AA patients and DEBR
rats (Figure 2e–h, q–t and Supplementary Figure S3c, d, g, and
h online). ALDH1A1 and ALDH1A2 were increased in
biopsies from humans, but were not different in rodent models
(Figure 2i–l and Supplementary Figure S6a–d online).
ALDH1A3 was greatly increased in mice, absent from the
pre-medulla in DEBR rats, and not different in biopsies from
humans, although no pre-medulla was present in human
samples (Figure 2m–p and Supplementary Figure S3e,
f online). Immunoreactivity of CYP26B1 was not different
between C3H/HeJ mice with AA or controls, but localization
changed during the hair cycle (data not shown). DHRS9,
ALDH1A1, and ALDH1A2 also localized to infiltrating
immune cells in biopsies from human patients with AA and
C3H/HeJ mice (Figure 2f, h, j, l and Supplementary Figure
S6a–d arrow online). In DEBR rats, immune cells expressed
DHRS9 but not ALDH1A1 or ALDH1A2 (Supplementary
Figure S3d online, data not shown). ALDH1A2 colocalized
with DC markers langerin and natural killer group 2D
(NKG2D; Supplementary Figure S6e, f arrow online).
Retinoid levels were measured by liquid chromatography/
mass spectometry (LC/MS/MS) and HPLC to confirm this
expression pattern. RA levels were significantly greater
(Po0.05), whereas retinol levels were lower (P¼ 0.061), in
AA mice compared with controls (Supplementary Figure S7a
and b online). There was no difference in retinyl ester levels
(Supplementary Figure S7c online).
Dietary vitamin A altered the progression of AA
To determine whether dietary vitamin A altered AA, C3H/
HeJ mice were fed one of the five diets, starting 2 weeks
before receiving a graft from a mouse with AA, and the
progression of the disease was analyzed. Ventral hair loss
was significantly increased at 13, 14, and 18 weeks post
grafting in mice fed high vitamin A (12 IU, VAH) compared
with mice fed unpurified chow (control, Figure 3a). There
was also a trend at 14 weeks with mice fed VAH diet having
more hair loss than mice fed the vitamin A–deficient diet
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(VAD, P¼0.055). Fifteen weeks after grafting, mice fed VAH
diet had significantly more epidermal hyperplasia in ventral
skin compared with mice fed VAD or adequate vitamin A (4
IU, VAA), or control diets (Figure 3b). Mice fed excess
vitamin A (28 IU, VAE) also had significantly more epider-
mal hyperplasia in ventral skin than mice fed VAD diet. The
percentage of hair follicles in mid-anagen through mid-
catagen, when active disease is seen, was also greater in
mice fed VAH and VAE diets compared with the control diet
in both ventral and dorsal skin (Figure 3c). In the dorsal skin,
these findings were also significantly greater than mice fed
VAA diet. By contrast, at 20 weeks post grafting, mice fed
VAD diet had significantly more lymphocytes and outer root
sheath hyperplasia in ventral skin compared with all other
diets (Figure 3d and e). Follicular dystrophy was significantly
greater in mice fed VAD, VAA, and VAH diets compared
with mice fed control diet (Figure 3f). Follicular dystrophy
was also significantly greater in mice fed VAD compared
with mice fed VAE diets. Similar results were seen in dorsal
skin, with mice fed VAD diet having significantly more
follicular dystrophy than mice fed VAH and VAE diets
(Po0.05, data not shown). Mice fed VAA diet also had
more follicular dystrophy than mice fed VAH diet (Po0.05,
data not shown).
There were no differences in body weight between any of
the groups (Supplementary Figure S8a online). Mice fed the
control diet ate more food than any of the other diets
(Po0.001), whereas mice fed VAH diet ate significantly less
than mice fed VAD, VAE, and control diets (Po0.05;
Supplementary Figure S8b online). Both food intake and body
weight increased with time as expected, yet neither was
significantly different between the mice receiving the AA
and sham grafts (Supplementary Figure S8a and b online).
Dietary vitamin A altered the number and localization of
granzyme B (GZMB)–positive cells
To determine how dietary vitamin A altered activated immune
cells in AA, IHC of GZMB was performed and positive cells
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counted in the bulb, superbular, isthmus, and infundibulum of
staged hair follicles. GZMB was significantly greater in AA
mice versus shams (Figure 4a, c, e and g). Further statistical
analysis was performed with only AA mice with hair follicles
in mid-anagen through mid-catagen, when disease is seen.
GZMB was greatest in mice fed VAE diet 15 weeks post
grafting in and around the isthmus (Figure 4d). GZMB peaked
at 10 weeks in and around the isthmus for mice fed VAH diet,
yet was high at both 10 and 15 weeks for mice fed VAA and
control diets. In contrast, mice fed VAD diet had a different
localization pattern with significantly more positive cells in
and around the bulb at 10 and 15 weeks than mice fed the
other diets (Figure 4h). At 10 weeks, most of the positive cells
were in and around the bulb and superbulbar, but by week 15
these mice had higher numbers of cells in and around the
isthmus (Figure 4d, f and h).
Figure 2. Retinoic acid synthesis enzymes and binding proteins are increased in alopecia areata. Immunohistochemistry (IHC) was performed on (a, e, i, m, q)
C3H/HeJ mouse skin collected 10 weeks after grafting with sham controls, (b, f, j, n, r) alopecia areata, (c, g, k, o, s) biopsies from human patients with tinea
capitis controls, (d, h, l, p, t) or alopecia areata with antibodies against (a–d) cellular retinol–binding protein (CRBP/RBP)1, (e–h) dehydrogenase reductase
SDR family member 9 (DHRS9), (i–l) 2, 3, retinal dehydrogenase 1, 2, 3 (ALDH1A1), (m–p) ALDH1A3, (q–t) and cellular retinoic acid–binding protein II
(CRABP2). Bar¼ 50mm. Arrow, positive immune cells.
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High vitamin A increased IL13 and reduced IFNc
Cytokines are differentially regulated in AA (Carroll et al.,
2002; Deeths et al., 2006; Freyschmidt-Paul et al., 2006;
McPhee et al., 2012). ELISAs were performed to determine
whether Th1, Th2, or Th17 cytokine protein levels were
differentially regulated by diet in mice. There were a few
diet differences. Mice fed VAH diet had significantly more
IL13 than control chow-fed mice, but there were no
differences between the AA and sham controls (Figure 5a).
Levels of IFNg varied at different times with different diets,
with low IFNg seen in mice fed VAH diet at 15 weeks and
mice fed VAE diet at 20 weeks (Figure 5b).
Cytokine production and PDL1 was reduced, whereas CXCL9
and CCL5 was increased, in AA
Protein levels of IL4, IL10, IL22, and IFNg were elevated in AA
mice compared with sham mice at 5 weeks, but this was only
significant for IL4 (Supplementary Figure S9a–c and f online).
All cytokines progressively decreased in the AA mice and
increased in the sham mice with time after grafting. By 20
weeks post grafting, IL10, IFNg, IL17, IL21, and IL22 were
significantly decreased in mice that received the AA graft
compared with sham controls (Supplementary Figure S9a–f
online). Two factors essential for tolerance, CTLA4 and PDL1
(CD274), were also tested in the skin by ELISA and IHC,
repectively. CTLA4 was significantly lower by 20 weeks, but
not significantly different between AA and sham mice
(Supplementary Figure S9g online). In contrast, PDL1
(CD274) was significantly lower in mice that received the
AA graft versus sham graft 15 and 20 weeks post grafting
(Supplementary Figure S9h online).
Quantitative real-time PCR analysis revealed that IFNg
mRNA levels were significantly increased in AA mice 15
weeks post grafting compared with sham controls, although
no diet effect was seen (Supplementary Figure S10 online).
To better select additional immune factors to analyze, an
ELISArray (Qiagen, Frederick, MD) was performed on the basis
of results from a gene microarray and quantitative real-time
PCR arrays (McPhee et al., 2012, ELISArray data not shown).
CCL5 (RANTES) and CXCL9 (MIG) were significantly
increased in the skin of mice receiving AA grafts compared
with sham controls at 10, 15, and 20 weeks post grafting
(Supplementary Figure S11a and b online). Neither chemokine
was altered by dietary vitamin A. Data for the control-fed mice
were previously published (McPhee et al., 2012).
DISCUSSION
This report shows that the expression of retinoid synthesis
enzymes and binding proteins is increased in human patients
with AA and in two rodent models. DCs and NKG2D-positive
cells also contained RA synthesis enzymes. RA levels were
also increased in C3H/HeJ mice with AA. Feeding high levels
of dietary vitamin A combined with increased RA synthesis
accelerated the onset of AA. Yet, not feeding vitamin A
resulted in more severe disease by the end of the study. This
duality of responses suggests that precise vitamin A levels are
needed. Analysis of immune factors showed that dietary
vitamin A altered GZMB, IL13, and IFNg, and provided
additional findings on AA pathogenesis. Regulation of the hair
cycle may have also contributed to the accelerated disease.
This report shows increased RA synthesis in AA. To our
knowledge, any studies of RA alterations in AA are previously
unreported. RA levels were also increased in the skin-specific
(Krt14-cre recombinase) Scd1tm2Ntam-null mice with cicatricial
alopecia (Flowers et al., 2011). The expression of RA synthesis
components was also increased in patients and C57BL/6J
mice with cicatricial alopecia (Everts et al., in press). Thus,
RA synthesis may be secondary to these diseases. Regardless
of how changes occurred, alteration in retinoid metabolism
may make patients with AA more sensitive to exogenous
retinoids.
Vitamin A toxicity leads to alopecia (Ruzicka et al., 1992;
Ries and Hess, 1999; Shih et al., 2009). In mice, excess retinol
and all transRA (Dgat1tm2Far null mice) within the basal
epidermis and outer root sheath (Krt14 cre) led to
progressive cyclical alopecia with accelerated telogen to
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anagen transition (Shih et al., 2009). This increased anagen
induction and alopecia could be reduced in Dgat1tm2Far-null
mice by severely reducing dietary vitamin A intake. In this
study, a moderate 3-fold increase in dietary vitamin A
accelerated AA onset, possibly by inducing anagen, the
target of AA. This dietary vitamin A level is well within the
amount consumed by Americans who take supplements (Park
et al., 2008). Thus, one mechanism for the increased AA with
high vitamin A may be to regulate the hair cycle.
Vitamin A may also directly regulate the immune response,
as RA regulates numerous immune cells (Duriancik et al.,
2010). Vitamin A increases Th2 and reduces Th1 cytokines
(Hoag et al., 2002; Iwata et al., 2003). The current study found
that high vitamin A reduced protein levels of the Th1 cytokine
IFNg and increased Th2 cytokine IL13 over the control diet. It
is noteworthy that there are many differences between these
diets besides the vitamin A content. The reduction in IFNg
may be important, as it was shown to have a key role in the
etiology of AA (Freyschmidt-Paul et al., 2005; Gilhar et al.,
2005; Freyschmidt-Paul et al., 2006; Nakamura et al., 2008).
Several studies reported increased skin IFNg mRNA levels,
similar to the current finding (Carroll et al., 2002; McPhee
et al., 2012). IFNg is regulated posttranscriptionally (Khabar
and Young, 2007), yet few studies have measured IFNg
protein levels in AA. Serum IFNg protein levels were
increased in patients with AA (Barahmani et al., 2009; Arca
et al., 2004). Within the skin of patients with long-standing
AA, IFNg levels were reduced (Deeths et al., 2006). This is
consistent with the drop in skin IFNg found in the current
study. Collectively, the results from these studies suggest that
although IFNg is essential for AA onset skin IFNg levels may
drop as AA progresses. High vitamin A may accelerate AA
toward a chronic stage and associated reduced IFNg. Future
studies should analyze IFNg protein levels in the serum,
spleen, and/or lymph nodes.
Vitamin A has a large role in maintaining gut immune
privilege (Duriancik et al., 2010). RA synthesized in DCs
increased FOXP3þ Tregs and reduced Th17 cells to maintain
mucosal immune tolerance. Increased Th17 cytokine levels
are hallmarks of autoimmune disease (Pelidou et al., 2000;
Nakae et al., 2003; Langrish et al., 2005). The current report
shows that ALDH1A2 localized to dermal DCs, but Th17 cells
probably do not contribute to AA in C3H/HeJ mice as cytokine
levels were reduced, not elevated. Th17 cytokines levels may
have been too reduced for vitamin A to have any further
effect. IL10, produced by numerous cell types (reviewed in
O’Garra et al., 2008), is a key immunosuppressive cytokine in
Treg differentiation (Asseman and Powrie, 1998; Asseman
et al., 1999). IL10 can also activate CD8þ T cells (Groux
et al., 1998), and IL10 therapy produced variable clinical
outcomes (O’Garra et al., 2008). AA frequency is reduced in
IL10-deficient mice (Freyschmidt-Paul et al., 2002), suggesting
that IL10 may activate CD8þ T cells and exacerbate the
disease. Vitamin A may regulate IL10, but results are
conflicting (Cantorna et al., 1994; Stephensen et al., 2004;
Maynard et al., 2009). In the current report, IL10 was highest
at 10 weeks, and then became significantly reduced as AA
progressed, but vitamin A had no effects. As IL10 has many
roles, it may be immunosuppressive in sham mice but
proinflammatory in AA mice. The reduction in IL10 at 20
weeks in AA may point to a loss in function or a reduction in
the number of Tregs in AA. Other studies (Zoller et al., 2002;
McElwee et al., 2005; Petukhova et al., 2010) provide indirect
evidence that Tregs are important in AA, as IL2 and its
receptor IL2A (CD25) were reduced in AA. IL2 is essential
for the maintenance and survival of Treg cells (Fontenot et al.,
2005). Overall, the results of this study suggest that although
Th17 cells may not be involved in AA Tregs possibly are.
There was no effect of dietary vitamin A on the immune
factors tested, but RA synthesis enzymes are localized to DCs.
Future studies on AA should examine factors such as FOXP3
and Treg function to further analyze the role(s) of vitamin A in
Treg responses in AA.
Both CTLA4 and PD1 (CD279) and its ligand PDL1 (CD274)
are essential for suppressing T-cell responses directly and
indirectly via Treg activation and preventing autoimmune
diseases (Fife and Bluestone, 2008). PDL1 is expressed in
many immune privileged sites. To our knowledge, a reduction
in PDL1 in AA that affected mouse hair follicles is previously
unreported. PDL1 reduction later in disease is consistent with
compromised immune tolerance (privilege) in AA. In contrast,
although CTLA4 decreased with time post grafting in AA
affected mouse skin, there were no significant differences
between AA and sham mice. These results conflict with gene
association studies in humans (Petukhova et al., 2010; John
et al., 2011) and functional studies in C3H/HeJ mice (Carroll
et al., 2002; McElwee et al., 2002; Sundberg et al., 2011)
linking CTLA4 to the pathogenesis of AA. One potential
reason for this difference may be the site tested. Skin was
examined in this study, but CTLA4 alterations may occur in
the spleen and/or lymph nodes and should be examined in
future studies in these sites. The PD1 pathway, a second
costimulatory pathway, should be examined for its role(s) in
the pathogenesis of AA.
Increased GZMB expression occurs in numerous autoim-
mune and skin diseases (Boivin et al., 2009; Afonina et al.,
2010). GZMB was localized to the dermis, subcutis, and hair
follicle connective tissue sheath in some but not all studies on
AA patients (Sato-Kawamura et al., 2003). Small numbers of
GZMB-positive cells were detected in the dermis of C3H/HeJ
mice and were increased by tachykinin 1 (substance P,
(Siebenhaar et al., 2007). None of these studies reported the
GZMB-positive cell localization within the hair follicle. In the
current study, GZMB-positive cells were detected around and
within the hair follicle, as well as in the isthmus—the site of
hair follicle stem cells (Cotsarelis et al., 1990) and immune
privilege collapse in AA (Meyer et al., 2008). Most studies
only mention GZMB’s role in inducing apoptosis, and some
argue against GZMB having a major role in killing follicular
cells in AA. More recent studies reveal additional roles for
GZMB in cleaving extracellular matrix proteins, autoantigens,
and receptors NOTCH1 and FGFR1 (Boivin et al., 2009).
These effects could negatively affect the hair follicle in AA by
altering both the stucture of the connective tissue sheath and
signaling within the hair follicle stem cells and dermal papilla.
Breakdown of the extracellular matrix can cause cell death
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because of loss of cell–matrix interactions, allow more
immune cells access to follicles, and contribute to collapse
of hair follicle immune privilege. Thus, altered immunoloca-
lization of GZMB by vitamin A may cause different types of
cellular damage at different follicular sites.
The chemokines tested in this study increased consistently
with recruitment of immune cells (Hayashi, 1982; Shimokawa
et al., 1983; Rathanaswami et al., 1993; Flier et al., 2001). The
increase in CCL5 and CXCL9 in C3H/HeJ mice is similar to
reported increases in gene and protein expression (Kuwano
et al., 2007; Subramanya et al., 2010) in patients with AA. The
colocalization of RA synthesis enzymes with NKG2D cells
suggests that AA may be altered by RA effects on these cells.
RA upregulates several NKG2D ligands (Cerwenka et al.,
2000; Jinushi et al., 2003; Poggi et al., 2009), which activate
NK, NKT, and CD8þ T cells (Mistry and O’Callaghan, 2007),
but whether and how vitamin A regulates NKG2D and its
ligands is unknown.
Initial attempts to treat AA with retinoids gave promising
results. Topical tretinoin (0.05%) alone (Much, 1976), or
combined with intralesional triamcinolone acetonide
(Kubeyinje and Cmathur, 1997), was effective in some
patients. The RXR agonist, bexarotene, also induced hair
regrowth in some patients (Talpur et al., 2009). None of
these studies had more than 42 patients, nor were they
controlled for spontaneous hair regrowth. In the current
study, high vitamin A accelerated the disease, arguing
against pharmacologic retinoids as an effective treatment for
AA. It is also possible that the patients who responded to
retinoid treatment were marginally vitamin A deficient and
that treatment corrected this deficiency. AA waxes and wanes;
therefore, the stage of disease at the time of treatment may
also alter retinoid effectiveness. In addition, studies in the gut
suggest that exogenous retinoids do not alter Tregs (Xiao et al.,
2008), whereas upregulating RA within DCs did (Housley
et al., 2009; Manicassamy et al., 2009), suggesting that
regulating DC RA production may be an effective treatment.
This study also highlights the need for precise regulation of RA
in AA patients with adequate dietary vitamin A, as excess
vitamin A from physicians and commercial sources such as
skin- and hair-care products (Arechalde and Saurat, 2000) and
dietary supplements (Park et al., 2008) may be detrimental.
MATERIALS AND METHODS
All procedures were carried out with approval from The Jackson
Laboratory IACUC for the microarray study, The Ohio State Uni-
versity IACUC for the diet study, and both IACUC boards for the mice
used for retinoid analysis. The microarray study was previously
reported (McPhee et al., 2012). Tissue arrays were created from
archived tissues (Sundberg et al., 1994, 1995; McElwee et al., 1998b,
1999). Biopsies from human patients (n¼ 2) were obtained from
archives at Vanderbilt University (Nashville, TN) and Baylor Hair
Research and Treatment Center (Dallas, TX, Supplementary Table S1
online). The Vanderbilt University Institutional Review Board
approved all human work. Rat paraffin blocks of skin with or without
AA (n¼ 3) were provided by Kevin McElwee at the University of
British Columbia. IHC and immunoflurescence were performed as
previously described (Everts et al., 2007; Duncan et al., 2009).
Primary antibodies against Langerin (eBiosciences, San Diego, CA),
NKG2D, GZMB, and PDL1 (CD274; R&D, Minneapolis, MN) were
purchased, whereas the remaning antibodies were prepared and
validated in Dr Ong’s laboratory (Everts et al., 2007) (Supplementary
Table S2 online).
In the second study, recipient mice (n¼ 10) were fed purified
AIN93M diets containing either 0 (VAD), 4 (VAA), 12 (VAH), or 28
(VAE) IU retinyl acetate per g diet (Research Diets, New Brunswick,
NJ), or control unpurified diet (chow, Harlen Teklad 7912, Indiana-
polis, IN), starting 2 weeks before grafting according to McElwee et al.
(1998a). Body weight, food intake, and hair loss were measured (Tang
et al., 2004) weekly and samples collected 5, 10, 15, and 20 weeks
post grafting. Histology was scored by JPS (Supplementary Figure S1
online). ELISA kits were purchased from R&D Systems, whereas the
ELISA array was purchased from SABiosciences (Frederick, MD), and
analyses were performed according to the kit instructions. RNA was
isolated using the RNAeasy Fibrous tissue kit (Qiagen, Valencia, CA),
cDNA prepared using the High Capacity cDNA Archive Kit (Applied
Biosystems, Carlsbad, CA), and quantitative real-time PCR performed
using a Taqman kit (Applied Biosystems).
Additional AA and sham mice (n¼ 6) were obtained (JPS) and
retinoids analyzed as previously described (Kane et al., 2008a, b).
Data were analyzed using SPSS, v19 (IBM; Armonk, NY) after
consultation with the OSU statistical consulting services. Histological
scores were analyzed using a generalized linear model with the
multinomial logistic response function at each time point. See the
figure legends for additional analyses.
See Supplementary Data online for more details.
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